NorthWest Biotherapeutics Inc (NWBO)

[CherryTree1]

Their last 10k for 1Q2021 has:
https://sec.report/Document/0001104659-21-068299/#nwbo-20210331x10q.htm
Research and other revenue $239,000 and the annual report has $1,291,000 for all of 2020 . . . so perhaps the London based specials programs have been providing free treatment for patients or vaccine at a substantial discount
. . . or perhaps they only treated a small number of patients like 2 per quarter . . . I don't know.

Again what Linda said at the ASM on May 18, 2021

Once we have the initial license, then we expect to begin producing vaccine products for our existing programs as we've been doing at the small facility in London that we've been using up 'til now.

It is a more forward looking statement. With production capabilities ramping up and getting approved if they go from treating 2 patients a quarter to say 20 a quarter then they could go for $239,000 to $2,390,000 a quarter or $9-10 million a year and more than that with higher volume.
. . . or they may continue to to just provide vaccine for free, but I would think this close to approval they will probably start charging especially since the need the money.
Hope that helps.